Ortho-McNeil Neurologics, Inc. clinical trials
A subsidiary of Johnson & Johnson
The registry lists 5 studies whose lead sponsor is Ortho-McNeil Neurologics, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jan 25, 2013.
Registry sponsor names on this page
- Ortho-McNeil Neurologics, Inc.5 studies
Something wrong with this grouping? Tell us on the Johnson & Johnson page.
Studies
Recruiting first, then most recently updated. Showing 5 of 5. All Johnson & Johnson studies →
- Use of Different Treatment Care Methods in Patients With Dementia Associated With Alzheimer's DiseaseCompletedNCT00283725
Sponsor listed in the registry: Ortho-McNeil Neurologics, Inc.
- Topiramate Versus Placebo as add-on Treatment in Patients With Bipolar Disorder in the Outpatient SettingCompletedNCT00237289Phase 3
Sponsor listed in the registry: Ortho-McNeil Neurologics, Inc.
- Evaluation of the Effectiveness of Topiramate in Preventing the Transformation From Episodic Migraine to Chronic Daily Headache.CompletedNCT00212810Phase 4
Sponsor listed in the registry: Ortho-McNeil Neurologics, Inc.
- The Effectiveness of Almotriptan Malate (AXERT®) 12.5 Milligrams When Taken at the Onset of Migraine PainCompletedNCT00212823Phase 4
Sponsor listed in the registry: Ortho-McNeil Neurologics, Inc.
- A Comparison of the Efficacy and Safety of Topiramate Versus Placebo in Preventing Migraine Headaches in ChildrenCompletedNCT00237302Phase 3
Sponsor listed in the registry: Ortho-McNeil Neurologics, Inc.